The Medicare agency is moving forward with drastic cuts to a drug discount program for hospitals operating in poor and low-income areas.
The pay cut, which goes into effect Jan. 1, slashes Medicare payments to hospitals for the drugs they buy under a government program known as the 340B drug discount program. The program, created under a 1992 law, allows certain hospitals and health-care providers to purchase drugs that are administered in outpatient hospitals from drug manufacturers at discounted prices. More than 2,000 hospitals participate in the program, and hospital groups say it is critical for many low-income and essential hospitals.
Hospitals in the program are currently reimbursed for physician-administered drugs at their average sales price, plus 6 percent. The Centers for Medicare & Medicaid Services in a final rule (RIN:0938-AT03) released Nov. 1 lowered the reimbursement rate to the drug’s average sales price, minus 22.5 percent, a nearly 30 percent cut. Rural sole community hospitals, children’s hospitals, and certain cancer hospitals are excluded from the reimbursement changes in 2018.
Hospital groups were quick to condemn the changes to the discount program and said they plan to sue over the rule.
“Essential hospitals operate with an average margin less than half that of other hospitals and depend on 340B program savings to stretch resources for patient care and community services,” Bruce Siegel, president and CEO of America’s Essential Hospitals, an industry group for safety-net hospitals, said in a Nov. 1 statement. He also said that given their weak financial position, essential hospitals will not weather the nearly 30 percent cut to Part B drug payments without scaling back services or jobs.
Read my full article here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)